scispace - formally typeset
Search or ask a question
Author

Bruce A. Runyon

University of California, Los Angeles
Other affiliations: UCLA Medical Center, University of Southern California, Loma Linda University Medical Center
Bio: Bruce A. Runyon is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Cirrhosis & Ascites. The author has an hindex of 21, co-authored 35 publications receiving 4333 citations. Previous affiliations of Bruce A. Runyon include UCLA Medical Center & University of Southern California.
Topics: Cirrhosis, Ascites, Spontaneous bacterial peritonitis, Alcoholic hepatitis, Paracentesis
Papers
More filters
Journal Article•DOI•
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis

[...]

Guadalupe Garcia-Tsao1, Arun J. Sanyal2, Norman D. Grace3, William D. Carey4, Margaret C. Shuhart, Gary L. Davis, Kiran Bambha, Andrés Cárdenas, Stanley Martin Cohen, Timothy J. Davern, Steven L. Flamm, Steven B. Han, Charles D. Howell, David R. Nelson, K. Rajender Reddy, Bruce A. Runyon, John B. Wong, Colina Yim, Nizar N. Zein, John M. Inadomi, Darren Baroni, David I. Bernstein, William R. Brugge, Lin Chang, William D. Chey, John T. Cunningham, Kenneth R. DeVault, Steven A. Edmundowicz, Ronnie Fass, Kelvin Hornbuckle, Costas Kefalas, Timothy R. Koch, Jenifer K. Lehrer, Anthony Lembo, John O'Brien, John Papp, Henry P. Parkman, Albert Roach, Richard E. Sampliner, Amnon Sonnenberg, Subbaramiah Sridhar, Miguel A. Valdovinos, John J. Vargo, Marcelo F. Vela, Nizar N. Zein •
Yale University1, Virginia Commonwealth University2, Harvard University3, Cleveland Clinic4
01 Sep 2007-Hepatology
TL;DR: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis Guadalupe Garcia-Tsao, M.D., co-authors.

1,467 citations

Journal Article•DOI•
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.

[...]

Guadalupe Garcia-Tsao1, Arun J. Sanyal2, Norman D. Grace3, William D. Carey4, Margaret C. Shuhart, Gary L. Davis, Kiran Bambha, Andrés Cárdenas, Stanley Martin Cohen, Timothy J. Davern, Steven L. Flamm, Steven B. Han, Charles D. Howell, David R. Nelson, K. Rajender Reddy, Bruce A. Runyon, John B. Wong, Colina Yim, Nizar N. Zein, John M. Inadomi, Darren Baroni, David I. Bernstein, William R. Brugge, Lin Chang, William D. Chey, John T. Cunningham, Kenneth R. DeVault, Steven A. Edmundowicz, Ronnie Fass, Kelvin Hornbuckle, Costas Kefalas, Timothy R. Koch, Jenifer K. Lehrer, Anthony Lembo, John O'Brien, John Papp, Henry P. Parkman, Albert Roach, Richard E. Sampliner, Amnon Sonnenberg, Subbaramiah Sridhar, Miguel A. Valdovinos, John J. Vargo, Marcelo F. Vela, Nizar N. Zein •
Yale University1, Virginia Commonwealth University2, Harvard University3, Cleveland Clinic4
01 Sep 2007-The American Journal of Gastroenterology
TL;DR: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis Guadalupe Garcia-Tsao, M.D., co-authors.

1,190 citations

Journal Article•DOI•
Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012

[...]

Bruce A. Runyon1•
University of California, Los Angeles1
01 Apr 2013-Hepatology
TL;DR: This version of the American Association for the Study of Liver Diseases Practice Guideline is the fourth iteration of this guideline and represents a thorough update of the 2009 version.

624 citations

Journal Article•DOI•
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis

[...]

Wichit Srikureja1, Namgyal L. Kyulo1, Namgyal L. Kyulo2, Bruce A. Runyon3, Bruce A. Runyon1, Ke-Qin Hu2, Ke-Qin Hu1 •
Loma Linda University Medical Center1, University of California, Irvine2, University of Southern California3
01 May 2005-Journal of Hepatology
TL;DR: It is indicated that in patients with alcoholic hepatitis, admission, first week, and first week change in MELD score are significantly independent predictors for in-hospital mortality.

198 citations

Journal Article•DOI•
Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States

[...]

Ke-Qin Hu1, Namgyal L. Kyulo1, Eric Esrailian2, Kevin Thompson3, Resa Chase4, Donald J. Hillebrand3, Bruce A. Runyon3 •
University of California, Irvine1, University of Southern California2, Loma Linda University Medical Center3, Veterans Health Administration4
01 Jan 2004-Journal of Hepatology
TL;DR: Being overweight/obese serves as an independent risk factor for hepatic steatosis in U.S. patients with CHC, and is independently associated with stage III/IV hepatic fibrosis in these patients.

144 citations

Cited by
More filters
Medscape

[...]

黄亚明
01 Feb 2009
TL;DR: This Secret History documentary follows experts as they pick through the evidence and reveal why the plague killed on such a scale, and what might be coming next.
Abstract: Secret History: Return of the Black Death Channel 4, 7-8pm In 1348 the Black Death swept through London, killing people within days of the appearance of their first symptoms. Exactly how many died, and why, has long been a mystery. This Secret History documentary follows experts as they pick through the evidence and reveal why the plague killed on such a scale. And they ask, what might be coming next?

5,234 citations

Journal Article•DOI•
The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

[...]

Naga Chalasani1, Zobair M. Younossi2, Joel E. Lavine3, Anna Mae Diehl4, Elizabeth M. Brunt5, Kenneth Cusi6, Michael Charlton7, Arun J. Sanyal8 •
Indiana University1, Inova Fairfax Hospital2, Columbia University3, Duke University4, Washington University in St. Louis5, University of Florida6, Mayo Clinic7, Virginia Commonwealth University8
01 Jun 2012-Hepatology
TL;DR: This is a practice guideline for clinicians rather than a review article and interested readers can refer to several comprehensive reviews published recently.

3,212 citations

Journal Article•DOI•
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

[...]

Paolo Angeli, Mauro Bernardi, Càndid Villanueva, Claire Francoz, Rajeshwar P. Mookerjee, Jonel Trebicka, Aleksander Krag, Wim Laleman, Pere Ginès 
01 Aug 2018-Journal of Hepatology
TL;DR: The panel of experts, having emphasised the importance of initiating aetiologic treatment for any degree of hepatic disease at the earliest possible stage, extended its work to all the complications of cirrhosis which had not been covered by the European Association for the Study of the Liver guidelines.

1,534 citations

Journal Article•DOI•
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

[...]

Naga Chalasani1, Zobair M. Younossi2, Joel E. Lavine3, Anna Mae Diehl4, Elizabeth M. Brunt5, Kenneth Cusi6, Michael Charlton7, Arun J. Sanyal8 •
Indiana University1, Inova Fairfax Hospital2, Columbia University3, Duke University4, Washington University in St. Louis5, University of Florida6, Mayo Clinic7, Virginia Commonwealth University8
01 Jun 2012-Gastroenterology
TL;DR: The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of GastroEnterology is published.

1,515 citations

Journal Article•
EASL Clinical Practice Guidelines: management of cholestatic liver diseases

[...]

Ulrich Beuers, Kirsten Muri Boberg, Roger W. Chapman, Olivier Chazouillères, Pietro Invernizzi, David Jones, Frank Lammert, Albert Parés, Michael Trauner 
01 Jan 2009-Journal of Hepatology
TL;DR: The clinical care for patients with cholestatic liver diseases has advanced considerably during recent decades thanks to growing insight into pathophysiological mechanisms and remarkable methodological and technical developments in diagnostic procedures as well as therapeutic and preventive approaches.

1,405 citations